Literature DB >> 1379008

Antigenic diversity of Rickettsia conorii.

D H Walker1, Q H Liu, X J Yu, H Li, C Taylor, H M Feng.   

Abstract

Analysis of seven strains designated as Rickettsia conorii for reactivity with a panel of 12 monoclonal antibodies to surface-protein epitopes of spotted fever group rickettsiae and by Western immunoblotting with standard serotyping sera revealed remarkable antigenic diversity. Rickettsial strains from France, Morocco, Ethiopia, Kenya, South Africa, India, and the USSR differed from one another in reactivity with at least one and as many as five monoclonal antibodies. Simko and Indian strains were similar to one another and differed substantially from other R. conorii strains. All seven strains reacted with three R. conorii-specific monoclonal antibodies. Western immunoblotting demonstrated a major 120-kD protein and a major 135-kD protein in all strains. The principal differences were the presence of a major undenatured 130-kD protein in all strains except Indian and Simko, which had an analogous protein of 124 kD. Immunodominant antigenically related, heat-denatured protein bands of 170 kD (Malish 7 strain), 175 kD (Manuel strain), and 190 kD (Kenya tick typhus, Indian, and Simko strains) were not detected in the M-1 and Moroccan strains. This antigenic diversity is greater than that previously reported for other spotted fever group rickettsial species, suggesting that R. conorrii is an older species than R. rickettsii with a longer period of time for evolutionary divergence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379008     DOI: 10.4269/ajtmh.1992.47.78

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

1.  Prevalence of antibodies to spotted fever group rickettsiae in the region of Split (southern Croatia).

Authors:  Volga Punda-Polić; Zorana Klismanić; Vesna Capkun
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 2.  Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

3.  Taxonomic relationships among spotted fever group rickettsiae as revealed by antigenic analysis with monoclonal antibodies.

Authors:  W Xu; D Raoult
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

4.  Antibodies against rickettsia in humans and potential vector ticks from Dhofar, Oman.

Authors:  M A Idris; A Ruppel; T Petney
Journal:  J Sci Res Med Sci       Date:  2000-01

5.  Production of monoclonal antibodies against Rickettsia massiliae and their use in antigenic and epidemiological studies.

Authors:  W Xu; D Raoult
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

6.  Characterization of and application of monoclonal antibodies against Rickettsia africae, a newly recognized species of spotted fever group rickettsia.

Authors:  W Xu; L Beati; D Raoult
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

7.  Prevalence of antibodies to spotted fever group rickettsiae along the eastern coast of the Adriatic sea.

Authors:  S Radulovic; D H Walker; K Weiss; B Dzelalija; M Morovic
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

8.  Differentiation among spotted fever group rickettsiae species by analysis of restriction fragment length polymorphism of PCR-amplified DNA.

Authors:  M Eremeeva; X Yu; D Raoult
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Gene sequence-based criteria for identification of new rickettsia isolates and description of Rickettsia heilongjiangensis sp. nov.

Authors:  Pierre-Edouard Fournier; J Stephen Dumler; Gilbert Greub; Jianzhi Zhang; Yimin Wu; Didier Raoult
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

10.  Rickettsia africae infection in man after travel to Ethiopia.

Authors:  Dorothea Stephany; Pierre Buffet; Jean-Marc Rolain; Didier Raoult; Paul H Consigny
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.